CompletedPhase 3NCT00765024
Ivermectin Versus Albendazole for Chronic Strongyloidiasis
Studying Strongyloidiasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Mahidol University
- Principal Investigator
- Yupin Suputtamongkol, MDMahidol University
- Intervention
- Ivermectin(drug)
- Enrollment
- 90 target
- Eligibility
- 18-90 years · All sexes
- Timeline
- 2008 – 2010
Study locations (1)
- Siriraj Hospital, Bangkoknoi, Bangkok, Thailand
Collaborators
Atlantic Laboratory Ltd
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00765024 on ClinicalTrials.gov